632 related articles for article (PubMed ID: 11435577)
1. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo.
Nakai H; Yant SR; Storm TA; Fuess S; Meuse L; Kay MA
J Virol; 2001 Aug; 75(15):6969-76. PubMed ID: 11435577
[TBL] [Abstract][Full Text] [Related]
2. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction.
Nakai H; Thomas CE; Storm TA; Fuess S; Powell S; Wright JF; Kay MA
J Virol; 2002 Nov; 76(22):11343-9. PubMed ID: 12388694
[TBL] [Abstract][Full Text] [Related]
3. Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.
Nakai H; Storm TA; Kay MA
J Virol; 2000 Oct; 74(20):9451-63. PubMed ID: 11000214
[TBL] [Abstract][Full Text] [Related]
4. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver.
Nakai H; Iwaki Y; Kay MA; Couto LB
J Virol; 1999 Jul; 73(7):5438-47. PubMed ID: 10364291
[TBL] [Abstract][Full Text] [Related]
5. Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver.
Ohashi K; Nakai H; Couto LB; Kay MA
Hum Gene Ther; 2005 Mar; 16(3):299-306. PubMed ID: 15812225
[TBL] [Abstract][Full Text] [Related]
6. Frequency and spectrum of genomic integration of recombinant adeno-associated virus serotype 8 vector in neonatal mouse liver.
Inagaki K; Piao C; Kotchey NM; Wu X; Nakai H
J Virol; 2008 Oct; 82(19):9513-24. PubMed ID: 18614641
[TBL] [Abstract][Full Text] [Related]
7. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction.
Miao CH; Nakai H; Thompson AR; Storm TA; Chiu W; Snyder RO; Kay MA
J Virol; 2000 Apr; 74(8):3793-803. PubMed ID: 10729154
[TBL] [Abstract][Full Text] [Related]
8. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice.
Nakai H; Fuess S; Storm TA; Muramatsu S; Nara Y; Kay MA
J Virol; 2005 Jan; 79(1):214-24. PubMed ID: 15596817
[TBL] [Abstract][Full Text] [Related]
9. Pathways of removal of free DNA vector ends in normal and DNA-PKcs-deficient SCID mouse hepatocytes transduced with rAAV vectors.
Nakai H; Storm TA; Fuess S; Kay MA
Hum Gene Ther; 2003 Jun; 14(9):871-81. PubMed ID: 12828858
[TBL] [Abstract][Full Text] [Related]
10. Ribosomal DNA integrating rAAV-rDNA vectors allow for stable transgene expression.
Lisowski L; Lau A; Wang Z; Zhang Y; Zhang F; Grompe M; Kay MA
Mol Ther; 2012 Oct; 20(10):1912-23. PubMed ID: 22990671
[TBL] [Abstract][Full Text] [Related]
11. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.
Song S; Embury J; Laipis PJ; Berns KI; Crawford JM; Flotte TR
Gene Ther; 2001 Sep; 8(17):1299-306. PubMed ID: 11571566
[TBL] [Abstract][Full Text] [Related]
12. Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction.
Gernoux G; Guilbaud M; Dubreil L; Larcher T; Babarit C; Ledevin M; Jaulin N; Planel P; Moullier P; Adjali O
Hum Gene Ther; 2015 Jan; 26(1):1-13. PubMed ID: 25333770
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression.
Clark KR; Sferra TJ; Lo W; Qu G; Chen R; Johnson PR
J Drug Target; 1999 Dec; 7(4):269-83. PubMed ID: 10682906
[TBL] [Abstract][Full Text] [Related]
14. AAV serotype 2 vectors preferentially integrate into active genes in mice.
Nakai H; Montini E; Fuess S; Storm TA; Grompe M; Kay MA
Nat Genet; 2003 Jul; 34(3):297-302. PubMed ID: 12778174
[TBL] [Abstract][Full Text] [Related]
15. DNA-dependent PK inhibits adeno-associated virus DNA integration.
Song S; Lu Y; Choi YK; Han Y; Tang Q; Zhao G; Berns KI; Flotte TR
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2112-6. PubMed ID: 14766968
[TBL] [Abstract][Full Text] [Related]
16. Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue.
Duan D; Yue Y; Engelhardt JF
J Virol; 2003 Apr; 77(8):4751-9. PubMed ID: 12663782
[TBL] [Abstract][Full Text] [Related]
17. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
18. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
Manno CS; Pierce GF; Arruda VR; Glader B; Ragni M; Rasko JJ; Ozelo MC; Hoots K; Blatt P; Konkle B; Dake M; Kaye R; Razavi M; Zajko A; Zehnder J; Rustagi PK; Nakai H; Chew A; Leonard D; Wright JF; Lessard RR; Sommer JM; Tigges M; Sabatino D; Luk A; Jiang H; Mingozzi F; Couto L; Ertl HC; High KA; Kay MA
Nat Med; 2006 Mar; 12(3):342-7. PubMed ID: 16474400
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.
Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC
Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of recombinant adeno-associated virus-mediated gene transfer.
Malik AK; Monahan PE; Allen DL; Chen BG; Samulski RJ; Kurachi K
J Virol; 2000 Apr; 74(8):3555-65. PubMed ID: 10729130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
